Development of adeno-associated viral vectors targeting cardiac fibroblasts for efficient in vivo cardiac reprogramming
Stem Cell Reports · 2024
DOI: 10.1016/j.stemcr.2024.08.002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Stem Cell Reports, 2024. Verfasst von Koji Nakano und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Institute of Medicine, University of Tsukuba, 1-1-1 Tennoudai, Tsukuba City, Ibaraki 305-8575, Japan. Hauptthemen laut MEDLINE: Dependovirus, Fibroblasts, Genetic Vectors, Cellular Reprogramming. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Overexpression of cardiac reprogramming factors, including GATA4, HAND2, TBX5, and MEF2C (GHT/M), can directly reprogram cardiac fibroblasts (CFs) into induced cardiomyocytes (iCMs). Adeno-associated virus (AAV) vectors are widely used clinically, and vectors targeting cardiomyocytes (CMs) have been extensively studied. However, safe and efficient AAV vectors targeting CFs for in vivo cardiac reprogramming remain elusive. Therefore, we screened multiple AAV capsids and promoters to develop efficient and safe CF-targeting AAV vectors for in vivo cardiac reprogramming. AAV-DJ capsids containing periostin promoter (AAV-DJ-Postn) strongly and specifically expressed transgenes in resident CFs in mice after myocardial infarction (MI). Lineage tracing revealed that AAV-DJ-Postn vectors expressing GHT/M reprogrammed CFs into iCMs, which was further increased 2-fold using activated MEF2C via the fusion of the powerful MYOD transactivation domain (M-TAD) with GHT (AAV-DJ-Postn-GHT/M-TAD). AAV-DJ-Postn-GHT/M-TAD injection improved cardiac function and reduced fibrosis after MI. Overall, we developed new AAV vectors that target CFs for cardiac reprogramming.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Institute of Medicine, University of Tsukuba, 1-1-1 Tennoudai, Tsukuba City, Ibaraki 305-8575, Japan.
- Department of Cardiology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan.
- Department of Cardiology, Institute of Medicine, University of Tsukuba, 1-1-1 Tennoudai, Tsukuba City, Ibaraki 305-8575, Japan; Division of Regenerative Medicine, Transborder Medical Research Center, Institute of Medici…
- Department of Cardiology, Institute of Medicine, University of Tsukuba, 1-1-1 Tennoudai, Tsukuba City, Ibaraki 305-8575, Japan; Department of Respiratory Medicine, Institute of Medicine, University of Tsukuba, 1-1-1 Ten…
- Department of Biomedical Engineering, University of Virginia, Charlottesville, VA 22908, USA.
- Division of Genetic Therapeutics, Center for Molecular Medicine, Jichi Medical University, 3311-1, Yakushiji, Shimotsuke, Tochigi 329-0498, Japan.
Zitieren
APA
Nakano, K., Sadahiro, T., Fujita, R., Isomi, M., Abe, Y., Yamada, Y., Akiyama, T., Honda, S., French, B. A., Mizukami, H., & Ieda, M. (2024). Development of adeno-associated viral vectors targeting cardiac fibroblasts for efficient in vivo cardiac reprogramming. Stem Cell Reports. https://doi.org/10.1016/j.stemcr.2024.08.002
Vancouver
Nakano K, Sadahiro T, Fujita R, Isomi M, Abe Y, Yamada Y, et al. Development of adeno-associated viral vectors targeting cardiac fibroblasts for efficient in vivo cardiac reprogramming. Stem Cell Reports. 2024. doi:10.1016/j.stemcr.2024.08.002
BibTeX
@article{Nakano2024,
author = {Nakano, Koji and Sadahiro, Taketaro and Fujita, Ryo and Isomi, Mari and Abe, Yuto and Yamada, Yu and Akiyama, Tatsuya and Honda, Seiichiro and French, Brent A and Mizukami, Hiroaki and Ieda, Masaki},
title = {Development of adeno-associated viral vectors targeting cardiac fibroblasts for efficient in vivo cardiac reprogramming},
journal = {Stem Cell Reports},
year = {2024},
doi = {10.1016/j.stemcr.2024.08.002}
}
EUVIMED